Figure 5 displays six signaling pathways (DNA replication, cell cycle, oxidative phosphorylation, homologous recombination, spliceosome, and proteasome) that were significantly enriched when SPARCL1 was downregulated in BC, revealing the potential molecular mechanisms by which SPARCL1 participates in BC occurrence and progression. The gene discussed is SPARCL1; the disease is breast cancer.